SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8,454 cases and 11,800 controls

Author： Wang Zhanwei   Fu Yuanyuan   Tang Chunbo   Lu Su   Chu Wen-ming  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.122, Iss.1, 2010-07, pp. : 193-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk

By Lu Pei-Hua  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 599-600

Springer Publishing Company

Access to resources Recommend Favorite

TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls

By Gu Dongying  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 857-861

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls

By Mao Chen  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 259-265

Springer Publishing Company

Access to resources Recommend Favorite

CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls

By Niu Yuming  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 182-187

Humana Press, Inc

Access to resources Recommend Favorite

The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis

By Yuan Weiguang  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 835-842

Springer Publishing Company

Access to resources Recommend Favorite